mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-05 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.04 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.06 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.03 |